144 related articles for article (PubMed ID: 15011398)
1. [Chronic acquired hepatocerebral degeneration].
Takeuchi H
Nihon Rinsho; 2004 Jan; 62 Suppl():419-23. PubMed ID: 15011398
[No Abstract] [Full Text] [Related]
2. [Chronic acquired(non-Wilsonian) hepatocerebral degeneration(CAHD)].
Takeuchi H
Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):136-8. PubMed ID: 11031915
[No Abstract] [Full Text] [Related]
3. Case of pediatric acquired chronic hepatocerebral degeneration.
Papapetropoulos S; Tzakis A; Sengun C; Reddy C; Boukas K; Zitser J; Singer C
Pediatr Neurol; 2008 Jan; 38(1):67-70. PubMed ID: 18054700
[TBL] [Abstract][Full Text] [Related]
4. [Chronic acquired hepatocerebral degeneration: the role of manganese and treatment by endovascular occlusion of a porto-systemic shunt].
Condat B; Dusoleil A; Bernardeau M; Roche A; Pelletier G; Buffet C
Gastroenterol Clin Biol; 1999 Feb; 23(2):268-70. PubMed ID: 10353021
[TBL] [Abstract][Full Text] [Related]
5. Acquired hepatocerebral degeneration.
Ferrara J; Jankovic J
J Neurol; 2009 Mar; 256(3):320-32. PubMed ID: 19224314
[TBL] [Abstract][Full Text] [Related]
6. [Neuroimaging of chronic acquired hepatocerebral degeneration].
Sánchez-Santos PJ; Yago-Escusa D; Fernández-Bedoya IU; Martínez-Sanz G
Rev Neurol; 2011 Apr; 52(7):435-6. PubMed ID: 21425113
[No Abstract] [Full Text] [Related]
7. [Acquired hepatocerebral degeneration].
Durán-Ferreras E; Robledo-Strauss A; Díaz-Espejo C
Rev Neurol; 2009 Mar 1-15; 48(5):274-6. PubMed ID: 19263399
[No Abstract] [Full Text] [Related]
8. Implications of Manganese in Chronic Acquired Hepatocerebral Degeneration.
Rajoriya N; Brahmania M; J Feld J
Ann Hepatol; 2019; 18(1):274-278. PubMed ID: 31113605
[TBL] [Abstract][Full Text] [Related]
9. Extraocular muscle dystonia due to acquired (non-Wilsonian) hepatocerebral degeneration.
Ferrara J; Gupta D; Foster E; Garman K; Stacy M
Mov Disord; 2008 Apr; 23(6):875-8. PubMed ID: 18361477
[TBL] [Abstract][Full Text] [Related]
10. [Wilson disease].
Shimizu N
Nihon Rinsho; 2004 Jan; 62 Suppl():399-403. PubMed ID: 15011394
[No Abstract] [Full Text] [Related]
11. Acquired hepatocerebral degeneration with middle cerebellar peduncles lesions: case report and review of the literature.
Ishii K; Shioya A; Fukuda K; Mori K; Tamaoka A
Clin Neurol Neurosurg; 2012 Dec; 114(10):1361-4. PubMed ID: 22551581
[No Abstract] [Full Text] [Related]
12. Recent Updates on Acquired Hepatocerebral Degeneration.
Shin HW; Park HK
Tremor Other Hyperkinet Mov (N Y); 2017; 7():463. PubMed ID: 28975044
[TBL] [Abstract][Full Text] [Related]
13. Acquired hepatocerebral degeneration in hepatitis C infection.
Khokhar N; Ahmad A; Butt MM
J Coll Physicians Surg Pak; 2005 Feb; 15(2):110-1. PubMed ID: 15730841
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric symptoms as the presenting feature of acquired hepatocerebral degeneration.
Gleason A; Hayhow B; Walterfang M; Evans A; Mocellin R; Gates P; Velakoulis D
Aust N Z J Psychiatry; 2014 Oct; 48(10):959-60. PubMed ID: 24740250
[No Abstract] [Full Text] [Related]
15. [Hepatic encephalopathy].
Maruyama K; Shirakura K
Ryoikibetsu Shokogun Shirizu; 2003; (40):466-70. PubMed ID: 14626162
[No Abstract] [Full Text] [Related]
16. [Chronic acquired hepatocerebral degeneration. Two case reports].
Martín Romano L; Alfredo Femminini R
Neurologia; 2007; 22(6):391-4. PubMed ID: 17610169
[TBL] [Abstract][Full Text] [Related]
17. Juvenile Parkinsonism.
Ware TL; Srinivasan J; Gonzalez L; Hardikar W; Scheinberg AM; Baker L; Prakash C; Ryan MM
J Paediatr Child Health; 2013 May; 49(5):409-11. PubMed ID: 22970882
[TBL] [Abstract][Full Text] [Related]
18. Reversible hepatocerebral degeneration-like syndrome due to portovenous shunts.
Güler S; Utku U; Tezel A; Unlü E
Ideggyogy Sz; 2013 Nov; 66(11-12):424-6. PubMed ID: 24555244
[TBL] [Abstract][Full Text] [Related]
19. Acquired hepatocerebral degeneration: MR similarity with Wilson disease.
Hanner JS; Li KC; Davis GL
J Comput Assist Tomogr; 1988; 12(6):1076-7. PubMed ID: 3183119
[TBL] [Abstract][Full Text] [Related]
20. Clinical and neuroradiological improvement in chronic acquired hepatocerebral degeneration after branched-chain amino acid therapy.
Ueki Y; Isozaki E; Miyazaki Y; Koide R; Shimizu T; Yagi K; Hirai S
Acta Neurol Scand; 2002 Aug; 106(2):113-6. PubMed ID: 12100372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
